MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Accumulated Expenses (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Accumulated Expenses came in at $32.9 million in Q4 2025, up 19.99% YoY from $27.4 million in Q4 2024, and up 37.79% on a QoQ basis from $23.9 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Accumulated Expenses (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Accumulated Expenses data on file, last reported at $32.9 million in Q4 2025.

  • Quarterly Accumulated Expenses rose 19.99% year-over-year to $32.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $32.9 million (up 19.99% YoY) and the FY2025 annual result came in at $32.9 million, up 19.99% from the prior year.
  • Accumulated Expenses rose to $32.9 million in Q4 2025, from $23.9 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $42.6 million in Q4 2023 to a low of $15.5 million in Q2 2025.
  • A 5-year average of $25.0 million and a median of $23.9 million in 2025 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2022 — Accumulated Expenses jumped 44.34% — and 2024, when it tumbled 44.14%.
  • Tracing MGTX's Accumulated Expenses over 5 years: stood at $27.6 million in 2021, then soared by 44.34% to $39.8 million in 2022, then climbed by 7.08% to $42.6 million in 2023, then slumped by 35.71% to $27.4 million in 2024, then rose by 19.99% to $32.9 million in 2025.
  • The last three Accumulated Expenses figures came in at $32.9 million (Q4 2025), $23.9 million (Q3 2025), and $15.5 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.23 Mn
Dec 31, 2025 32.89 Mn
Sep 30, 2025 23.87 Mn
Jun 30, 2025 15.48 Mn
Mar 31, 2025 23.96 Mn
Dec 31, 2024 27.41 Mn
Sep 30, 2024 19.34 Mn
Jun 30, 2024 16.93 Mn
Mar 31, 2024 17.35 Mn
Dec 31, 2023 42.64 Mn
Sep 30, 2023 28.25 Mn
Jun 30, 2023 24.89 Mn
Mar 31, 2023 31.07 Mn
Dec 31, 2022 39.82 Mn
Sep 30, 2022 24.77 Mn
Jun 30, 2022 23.57 Mn
Mar 31, 2022 23.18 Mn
Dec 31, 2021 27.59 Mn
Sep 30, 2021 21.93 Mn
Jun 30, 2021 17.56 Mn